Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Lands, Larry C ^a   Stanojevic, S ^b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b NONE

Author keywords

Administration, oral; Anti inflammatory agents, non steroidal *therapeutic use ; Cystic fibrosis *drug therapy ; Humans; Randomized controlled trials as topic

Indexed keywords

ANTIBIOTIC AGENT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLACEBO;

ABDOMINAL PAIN; BRAIN HEMORRHAGE; BRONCHOSPASM; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CYSTIC FIBROSIS; DIARRHEA; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INDUSTRY; DRUG MECHANISM; DRUG WITHDRAWAL; DYSPEPSIA; EPIGASTRIC PAIN; EPISTAXIS; FEVER; FLUID RETENTION; FORCED EXPIRATORY VOLUME; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEPATITIS; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; LONG TERM CARE; LUNG FUNCTION; MEDICAL LITERATURE; MEDICAL RESEARCH; MORNING DOSAGE; NAUSEA; NONHUMAN; NUTRITIONAL STATUS; OCCULT BLOOD; PATIENT COMPLIANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; REACTIVE ARTHRITIS; REFLUX ESOPHAGITIS; RESPIRATORY FUNCTION; REVIEW; SIDE EFFECT; STROKE; SURVIVAL; TINNITUS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 44949151079     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001505.pub2     Document Type: Review

References (24)

1. Konstan 1991 {published data only} Konstan MW, Hoppel CL, Chai B, Davis PB. Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects. Journal of Pediatrics 1991;118(6):956-64.
2. Konstan 1995 {published data only} Konstan MW. Systemic anti-inflammatory treatment NSAID [abstract]. Proceedings of the 20th European Cystic Fibrosis Conference; 1995 June 18-21; Brussels, Belgium. 1995:L51.
3. *Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. New England Journal of Medicine 1995;332(13):848-54.
4. Konstan MW, Davis PB, Byard PJ, Hoppel CJ. Results of a four-year, randomized, placebo-controlled, double-blind trial of high-dose ibuprofen in CF patients with mild lung disease [abstract]. Pediatric Pulmonology 1994;Suppl 10:S6.4.
5. Lands 2007 {published data only} Lands LC, Corey M, Milner R, Kilcullen A, Cantin AM. High dose ibuprofen in CF children: the Trans-Canadian trial [abstract]. Pediatric Pulmonology 2002;34(Suppl 24):276.
6. *Lands LC, Milner R, Cantain AM, Manson D, Corey M. High-dose Ibuprofen in Cystic Fibrosis: Canadian Safety and Effectiveness Trial. Journal of Pediatrics 2007;151(3):249-54.
7. Sordelli 1994 {published data only} Sordelli DO, Macri CN, Maillie AJ. A study on the effect of Piroxicam (PIR) treatment to prevent lung damage in CF patients with Pseudomonas aeruginosa (Psa) pneumonia [abstract]. Pediatric Pulmonology 1990;Suppl 5:215.
8. Sordelli DO, Macri CN, Maillie AJ, Cerquetti MC. A preliminary study of the effect of anti-inflammatory treatment in cystic fibrosis patients with pseudomonas aeruginosa lung infection. International Journal of Immunopathology and Pharmacology 1994;7(2):109-17.
9. Noritake 1982 Noritake D, Hen J, Dolan TF. Effects of aspirin on pulmonary function in patients with cystic fibrosis [abstract]. Proceedings of the 22nd Annual Meeting Cystic Fibrosis Club Abstracts; 1981 May 1; San Francisco, California. 1981:144.
10. *Noritake DT, Hen J, Leo L, Dolan TF. The influence of aspirin on lung function in cystic fibrosis. Connecticut Medicine 1982;46:574-6.
11. Shmarina 2004 Shmarina GV, Pukhalsky AL, Kashirskaja NJ. Anti-inflammatory therapy in cystic fibrosis: a comparative study in the treatment with nimesulide (selective cyclooxygenase-2 inhibitor) and clarithromycin (14-memebered ring macrolide antibiotic) [abstract]. European Respiratory Journal 2004;24(Suppl 48):P3758.
12. Bertenshaw 2007 Bertenshaw C, Watson A, Lewis S, Smyth A. A survey of acute renal failure in cystic fibrosis patients in the United Kingdom. http: //thorax.bmj.com/ (accessed 30 January 2007).
13. Chmiel 2002 Chmiel JF, Berger M, Konstan MW. The role of inflammation in the pathophysiology of CF lung disease. Clinical Reviews in Allergy & Immunology 2002;23(1):5-27.
14. Gibson 2003 Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. American Journal Respiratory and Critical Care Medicine 2003;168(8):918-51.
15. Konstan 1990 Konstan MW, Vargo KM, Davis PB. Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. American Review of Respiratory and Critical Care Medicine 1990;141(1):186-92.
16. Konstan 1997 Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatric Pulmonology 1997;24(2):137-42.
17. Konstan 1999 Konstan MW. Personal Communication 1999.
18. Konstan 2003 Konstan MW, Krenicky JE, Finney MR, Kirchner HL, Hilliard KA, Hilliard JB, et al.Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects. Journal of Pharmacology and Experimental Therapeutics 2003;306(3):1086-91.
19. Kovesi 1998 Kovesi TA, Swartz R, MacDonald N. Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis (letter). New England Journal of Medicine 1998;338(1): 65-6.
20. Rosenstein 1998 Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. Journal of Pediatrics 1998;132(4):589-95.
21. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.
22. Southern 2004 Southern KW, Barker PM, Solis A. Macrolide anitbiotics for cystic fibrosis (Cochrane Review). Cochrane Database of Systematic Reviews 2004, Issue 3.
23. Wheeler 1984 Wheeler WB, Williams RN, Matthews WJ, Colten HR. Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. Journal of Pediatrics 1984;104 (5):685-99.
24. Dezateux 1999 Dezateux C, Crighton A. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis (Cochrane review). Cochrane Database of Systematic Reviews 1999, Issue 2.